A Study of VX-445 in Healthy Subjects and Subjects With Cystic Fibrosis
Clinical trial NCT03227471 · COMPLETED
Trial details
- NCT number
- NCT03227471
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-23
- Primary completion
- 2018-03-27
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.